Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  WebMD Health Corp.    WBMD

Delayed Quote. Delayed  - 08/25 06:23:29 pm
52.1 USD   -0.65%
08/11 WEBMD HEALTH : "Innovations in Care with Soledad O'Brien" Premieres ..
08/09DJU.S. HOT STOCKS : Hot Stocks to Watch
08/08 WEBMD HEALTH : tops Street 2Q forecasts
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales515580636706762823
Operating income (EBITDA)84,3159193228256283
Operating profit (EBIT)57,796,3129162186209
Pre-Tax Profit (EBT)28,8-----
Net income15,142,178,187,0103116
P/E ratio12739,632,628,725,823,2
EPS ( $ )0,311,001,481,832,042,26
Dividend per Share ( $ )------
Yield------
Reference price ( $ )39.539.5548.352.4452.4452.44
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1272451622,28--
Finance----1 178945
Operating income (EBITDA)84,3159193228256283
Leverage
(Debt/EBITDA)
1,51x1,55x0,84x0,01x--
Capital Expenditure-23,248,433,130,431,8
Book Value Per Share (BVPS)4,25 $-----
Cash Flow per Share------
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 2 044 M$ -
Entreprise Value (EV) 2 047 M$ 866 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 28,7x 25,8x
Capitalization / Revenue 2,90x 2,68x
EV / Revenue 2,90x 1,14x
EV / EBITDA 8,97x 3,39x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 23,0% 24,4%
operating Leverage (Delta EBIT / Delta Sales) 2,38x 1,83x
Net Margin (Net Profit / Revenue) 12,3% 13,6%
ROA (Net Profit / Asset) 6,10% 6,20%
ROE (Net Profit / Equities) 37,3% 30,6%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   4,68% 3,98%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 2,02x 2,19x
Financial Leverage (Net Debt / EBITDA) 0,01x -4,61x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend